AbbVie
US.ABBV
256.46
-3.75
-1.44%
AbbVie
256.46
-3.75
-1.44%
Collector offline (last heartbeat: 15941s ago)
· 2026-09-04 20:02
Pre-market
259.19
-0.39%
After-hours
256.53
+0.03%
Overnight
259.13
-0.42%
✦ AI Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 20 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.1 percentage points.
Institutional ownership
- Held by institutions
- 76.71% -0.10pp
- Institutions
- 4,730 -20
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund63.00%
Public Company5.38%
Private Company2.29%
Government Pension Fund2.00%
Sovereign Wealth Fund1.53%
Hedge Fund1.24%
Family Office/Trust0.51%
Insurance Company0.35%
Corporate Pension Plan0.19%
Other23.51%
Top holders
| Holder | Stake |
|---|---|
| BlackRock | 8.46% |
| Vanguard Capital Management, LLC | 7.09% |
| State Street Global Advisors | 4.67% |
| Capital Research | 3.71% |
| Vanguard Portfolio Management, LLC | 2.74% |
| Other | 73.32% |
Insiders
25 filings tracked · 11 buys · 1 sells
| Name | Role | Stake |
|---|---|---|
| Richard Gonzalez | Chairperson & CEO | 0.02% |
| Azita Saleki | Chief Operating Officer | 0.01% |
| Robert Michael | President | 0.01% |
| Thomas Freyman | Independent Director | 0.01% |
| Jeffrey Stewart | Executive Vice President | 0.00% |
| Nicholas Donoghoe | Executive VP and Chief Business & Strategy Officer | 0.00% |
| Roopal Thakkar | SVP of Development & Regulatory Affairs and Chief Medical Officer | 0.00% |
| Scott Reents | Chief Financial Officer | 0.00% |
| Glenn Tilton | Lead Independent Director | 0.00% |
| Edward Rapp | Independent Director | 0.00% |
Quote time 2026-09-04 20:02:13 · For reference only, not investment advice.